Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis.
about
The niche under siege: novel targets for metastasis therapyProteomics of ovarian cancer: functional insights and clinical applicationsApplication of gel-based proteomic technique in female reproductive investigationsSialoglycoproteins and N-glycans from secreted exosomes of ovarian carcinoma cellsDiscovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomicsCharacterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4.An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors."The quest for biomarkers": are we on the right technical track?Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation statusMass spectrometry based glycoproteomics--from a proteomics perspectiveComparative studies of the proteome, glycoproteome, and N-glycome of clear cell renal cell carcinoma plasma before and after curative nephrectomyProtein biomarkers of ovarian cancer: the forest and the treesGlycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functionsAberrant glycosylation associated with enzymes as cancer biomarkers.Cell surface nucleolin facilitates enterovirus 71 binding and infection.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures.Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients.Unlocking Cancer Glycomes from Histopathological Formalin-fixed and Paraffin-embedded (FFPE) Tissue Microdissections.Analytical glycobiology at high sensitivity: current approaches and directionsDifferential network analysis reveals the genome-wide landscape of estrogen receptor modulation in hormonal cancersGlycoprotein disease markers and single protein-omicsOvarian cancer: can proteomics give new insights for therapy and diagnosis?Recent trends in analytical and structural glycobiologyIntegrated glycomic analysis of ovarian cancer side population cells.Use of Aleuria alantia Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer.High-sensitivity analytical approaches for the structural characterization of glycoproteins.Recent advances in the MS analysis of glycoproteins: Theoretical considerations.Recent advances in the MS analysis of glycoproteins: Capillary and microfluidic workflows.Profiling for novel proteomics biomarkers in neurodevelopmental disorders.Cancer proteomics.Cell surface protein glycosylation in cancer.Quantitative mass spectrometric analysis of glycoproteins combined with enrichment methods.Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays.Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma.Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.Glycoproteomics-based identification of cancer biomarkers.Complementary Glycomic Analyses of Sera Derived from Colorectal Cancer Patients by MALDI-TOF-MS and Microchip Electrophoresis.
P2860
Q26849444-956D0DC9-6282-4C8F-B5AE-B0B3CCCF036FQ28082632-6A921FC3-3B6C-46DF-8A0E-EBB097EDB555Q28083354-EF138F44-BDDA-4C2F-95CB-F6BDE5A3782AQ28535417-A3B14D73-1299-4156-87F1-E6FA17B87ADBQ28539618-C0E7FBAA-94E8-4282-8CB0-99C6E67B09DDQ33564920-71FDA4C2-BDD0-47F3-AF56-622AEB0A4755Q33655094-74195958-BE6F-428A-BFC5-900B4F2B75DBQ34116103-BBC0F314-A6B4-4664-B67B-4A55417698B1Q34157637-4703A87E-8E35-470A-9A48-98C0E9EDF687Q34454989-EFA083B4-9D92-4C5C-AF41-D3C5E0C8EEC9Q34488550-15A6E1DF-C244-47D0-AE9D-D0B88BF0BC14Q34634143-95CF27C3-207F-4302-BAF6-9EEEF33979C8Q34856178-365266B3-9A8D-4D03-8950-80B8919B49FFQ35206309-E32809E4-EFC0-48E7-A884-F0D85D60297CQ35641079-5B06F2B1-7ED2-408A-97CB-D0715EA67FE7Q35837949-D2D4934B-7DCF-4F6A-9C04-C1363EF4763EQ35874750-4EA7E7A6-8BF2-4903-A8DB-48D3EAC902BEQ36076879-AD7DD86F-E8A2-4AA0-984A-8D5FAA43313AQ36139088-3EBE0BD5-E0AB-4E46-9538-0DADDAD723ABQ36169039-52D09625-33EC-4FAF-A7AF-65597769617BQ36260470-D19E83DE-96E0-4B1B-BD1F-B1C0A3958CEDQ36651493-74F047D1-370D-4A89-A361-E22162908C08Q36682166-7EE2CAF1-FCB0-423C-9797-7D133C8F0BD7Q36742398-BF6D8EAD-B31F-4EED-A52B-528B15AAE346Q36820579-A8A23C96-C999-421D-AFE0-5F49646D18C9Q37297209-FDABD770-B76D-46E4-A1FB-DF39BABD310EQ37405898-99E8ABF4-0F1D-496A-86FE-E9BC631B16DFQ37566478-13D2FF83-4AB8-4809-BE00-0E89916384CEQ37712517-7A67C83C-2DA1-468C-89AC-D3EAA02DE243Q37822366-954AD8AC-5D39-4842-B124-9162116E82C3Q37822367-0BFD3A77-FB42-420D-8A64-2A2B842FB4EAQ37844157-CD302812-E257-49FA-8AD8-6A0E56B8D3A9Q37994133-9D46F633-524E-4775-9CEB-6D0B4347118CQ38171440-17BAC04C-16EC-4ED6-81A3-81710D794DEEQ38217009-F2849A40-DDF2-42E2-B3C7-E279928D7354Q38500988-5F607F1B-2581-43A3-9790-132AD9C1DD68Q38602517-372FDA71-537E-421F-9AEE-C09EC8941118Q38686032-39247577-B032-4B7F-B331-70110F772D35Q38738207-380AA7D9-7E58-428F-B2A3-20D37E142907Q39440452-83C82D40-D4A4-45F8-8B01-FF5AB51DDE70
P2860
Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of candidate bi ...... ts by glycoproteomic analysis.
@en
Identification of candidate bi ...... ts by glycoproteomic analysis.
@nl
type
label
Identification of candidate bi ...... ts by glycoproteomic analysis.
@en
Identification of candidate bi ...... ts by glycoproteomic analysis.
@nl
prefLabel
Identification of candidate bi ...... ts by glycoproteomic analysis.
@en
Identification of candidate bi ...... ts by glycoproteomic analysis.
@nl
P2093
P2860
P921
P356
P1433
P1476
Identification of candidate bi ...... ts by glycoproteomic analysis.
@en
P2093
Benedict B Benigno
Jae-Min Lim
John F McDonald
Karen L Abbott
Lance Wells
Michael Pierce
P2860
P304
P356
10.1002/PMIC.200900537
P577
2010-02-01T00:00:00Z